Skip navigation
Skip navigation

The efficacy of cidofovir treatment of mice infected with ectromelia (mousepox) virus encoding interleukin-4

Robbins, S; Jackson, Ronald; Fenner, Frank; Beaton, S; Medveczky, C; Ramshaw, Ian; Ramsay, Alistair


Improved vaccines and therapies for virulent poxvirus infection are required, particularly in the light of recent threats of bioterrorism. Cidofovir (HPMPC) is an acyclic nucleoside analog with proven efficacy against poxviruses. Here, we evaluated HPMPC

CollectionsANU Research Publications
Date published: 2005
Type: Journal article
Source: Antiviral Research
DOI: 10.1016/j.antiviral.2004.12.003


File Description SizeFormat Image
01_Robbins_The_efficacy_of_cidofovir_2005.pdf143.41 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator